Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Physostigmine salicylate |
Is a |
False |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Physostigmine adverse reaction |
Causative agent (attribute) |
True |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to physostigmine (finding) |
Causative agent (attribute) |
False |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Physostigmine 0.25% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Physostigmine 0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Physostigmine+pilocarpine 0.25%+2% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Physostigmine+pilocarpine 0.25%+4% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Physostigmine+pilocarpine 0.5%+4% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Eserine sulfate 1.0% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing physostigmine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing physostigmine and pilocarpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Physostigmine sulfate |
Is a |
False |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing physostigmine in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Physostigmine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to physostigmine (finding) |
Causative agent (attribute) |
True |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Physostigmine salicylate |
Is modification of (attribute) |
True |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Physostigmine sulfate |
Is modification of (attribute) |
True |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Physostigmine-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Physostigmine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only physostigmine and pilocarpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Physostigmine only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only physostigmine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Physostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |